Daniel A. Osman, MD, Founder and Course Director of the Miami Breast Cancer Conference

Article

Daniel A. Osman, MD, talks about detecting malignant tumors in patients

Related Videos
Chamil Codipilly, MD: Vonoprazan and PCABs for GERD
Christoph Correll, MD: New Paliperidone Palmitate Data for Schizophrenia
Taha Qazi, MD: Evolving Bariatric Surgery Value in GI
Taha Qazi, MD: Best Screening for Colorectal Cancer
Anita Clayton, MD: Zuranolone for Postpartum Depression
Taha Qazi, MD: Finding Upadacitinib's Role in Crohn's Disease
Related Content

Applying New NAFLD Recommendations in Type 2 Diabetes, with Sarah Wheeler, PharmD, and John Bucheit, PharmD

September 22nd 2023

New Insight: A Look at Avacincaptad Pegol with Pravin Dugel, MD

April 23rd 2023

Semaglutide for HFpEF? Breaking Down the STEP-HFpEF Trial, with Javed Butler, MD

August 27th 2023

Introducing New Cancer Care Strategies to Patients

July 28th 2021

Breaking Down Tirzepatide and SURMOUNT-2 Data, with W. Timothy Garvey, MD

June 26th 2023

SGLT2 Inhibitor Prescription Rates Lag Behind in HFrEF, with Stephen Greene, MD

June 13th 2023

Applying New NAFLD Recommendations in Type 2 Diabetes, with Sarah Wheeler, PharmD, and John Bucheit, PharmD

September 22nd 2023

New Insight: A Look at Avacincaptad Pegol with Pravin Dugel, MD

April 23rd 2023

Semaglutide for HFpEF? Breaking Down the STEP-HFpEF Trial, with Javed Butler, MD

August 27th 2023

Introducing New Cancer Care Strategies to Patients

July 28th 2021

Breaking Down Tirzepatide and SURMOUNT-2 Data, with W. Timothy Garvey, MD

June 26th 2023

SGLT2 Inhibitor Prescription Rates Lag Behind in HFrEF, with Stephen Greene, MD

June 13th 2023

Applying New NAFLD Recommendations in Type 2 Diabetes, with Sarah Wheeler, PharmD, and John Bucheit, PharmD

September 22nd 2023

New Insight: A Look at Avacincaptad Pegol with Pravin Dugel, MD

April 23rd 2023

Semaglutide for HFpEF? Breaking Down the STEP-HFpEF Trial, with Javed Butler, MD

August 27th 2023

Introducing New Cancer Care Strategies to Patients

July 28th 2021

Breaking Down Tirzepatide and SURMOUNT-2 Data, with W. Timothy Garvey, MD

June 26th 2023

SGLT2 Inhibitor Prescription Rates Lag Behind in HFrEF, with Stephen Greene, MD

June 13th 2023
© 2023 MJH Life Sciences

All rights reserved.